NASDAQ:CBIO
Delisted
Catalyst Biosciences Stock News
$0.511
+0 (+0%)
At Close: Dec 14, 2023
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and PTC Therapeutics (PTCT)
10:14am, Wednesday, 08'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics (BNGO) and PTC Therapeutics (PTCT) with
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (NASDAQ: BNGO) and PTC Therapeutics (NASDAQ: PTCT)
10:14am, Wednesday, 08'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics
Catalyst Biosciences Announces Pivotal Phase 3 Study Design for MarzAA in Individuals with Hemophilia A or B with Inhibitors
12:00pm, Monday, 06'th Apr 2020
SOUTH SAN FRANCISCO, Calif., April 06, 2020 -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company that is developing novel subcutaneous (SQ) therapies for.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moleculin Biotech (MBRX
Analysts Are Bullish on These Healthcare Stocks: Vericel (VCEL), Immunomedics (IMMU)
05:28pm, Thursday, 02'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vericel (VCEL) and Immunomedics (IMMU) with bullish
Analysts Are Bullish on These Healthcare Stocks: Vericel (VCEL), Immunomedics (IMMU)
05:28pm, Thursday, 02'nd Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vericel (
VCEL
–
Research Report
) and Immunomedics (
IMMU
–
Research Report
) with bullish sentime
Invitae (NVTA) Gets a Buy Rating from Oppenheimer
01:17am, Thursday, 02'nd Apr 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Invitae (NVTA) yesterday and set a price target of $25.00. The company's shares closed last
Invitae (NVTA) Gets a Buy Rating from Oppenheimer
01:17am, Thursday, 02'nd Apr 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Invitae (NVTA – Research Report) yesterday and set a price target
FDA OKs new hemophilia treatment
05:51pm, Wednesday, 01'st Apr 2020
The FDA approves LFB Biotechnologies' Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes in adults and adolescents at least 12 years old with he
How Much is Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Getting Paid?
01:02pm, Sunday, 29'th Mar 2020
Nassim Usman became the CEO of Catalyst Biosciences, Inc. (NASDAQ:CBIO) in 2015. This analysis aims first to contrast...
Lawrence Livermore Lab Uses Artificial Intelligence and Supercomputers in Global Fight Against COVID-19
04:35pm, Thursday, 26'th Mar 2020
Lawrence Livermore National Laboratory (LLNL) scientists are contributing to the global fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics, and supercomputing
Lab antibody, antiviral research aids COVID-19 response
02:40pm, Wednesday, 25'th Mar 2020
Lawrence Livermore National Laboratory (LLNL) scientists are contributing to the global fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics and supercomputing
A Single X-Ray Strike Is Enough to Destroy an Entire Molecule
01:48pm, Friday, 20'th Mar 2020
Radiation damage spreads among close neighbors: A single soft x-ray can destroy a protein-sized molecule. A single x-ray can unravel an enormous molecule, physicists report in the March 17 issue of Ph
Analysts' Top Healthcare Picks: Xeris Pharmaceuticals (XERS), Verastem (VSTM)
01:13pm, Friday, 20'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xeris Pharmaceuticals (XERS) and Verastem (VSTM) with
Analysts’ Top Healthcare Picks: Xeris Pharmaceuticals (XERS), Verastem (VSTM)
01:13pm, Friday, 20'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xeris Pharmaceuticals